Tag: linagliptin
The Delhi High Court rejects Boehringer Ingelheim’s request for a temporary restraining order, and generic linagliptin production is permitted.
In a patent dispute involving the former’s diabetes drug linagliptin, a single judge of the Delhi High Court…
Registration Form
This will close in 0 seconds
